NEW #Alzheimer’s Drug Controversy Continues ‣
In four papers, #researchers and journalists take on aducanumab's controversial #FDAapproval
Their mission? Analyze what went wrong
top of page
Search
bottom of page
In four papers, #researchers and journalists take on aducanumab's controversial #FDAapproval
Their mission? Analyze what went wrong